arthyperАртериальная гипертензия"Arterial’naya Gipertenziya" ("Arterial Hypertension")1607-419X2411-8524Antihypertensive Leaguearthyper-978Research ArticleОБЗОРЫREVIEWSАспирин и первичная профилактика ишемической болезни сердцаЛагутаП. С.noemail@neicon.ruИнститут кардиологии им. А.Л. Мясникова РКНПК МЗ и СР РФRussian Federation200528042005112116119Copyright © Лагута П.С., 20052005Лагута П.С.Лагута П.С.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://htn.almazovcentre.ru/jour/article/view/978ReferencesHunink M.G., Goldman L., Tosteson A.N. et al. The recent decline in mortality from coronary heart disease. I980-1990: the effect of secular trends in risk factors and treatment. JAMA 1997; 277: 535-42.Hunink M.G., Goldman L., Tosteson A.N. et al. The recent decline in mortality from coronary heart disease. I980-1990: the effect of secular trends in risk factors and treatment. JAMA 1997; 277: 535-42.McConnel H. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br Med J 2002: 324: 71-86.McConnel H. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br Med J 2002: 324: 71-86.Hennekens C.H., Karlson L.K., Rosner B. A case-control study of regular aspirin use and coronary deaths. Circulation 1978; 58; 35-8.Hennekens C.H., Karlson L.K., Rosner B. A case-control study of regular aspirin use and coronary deaths. Circulation 1978; 58; 35-8.Hammond E.C., Carfinkel L. Aspirin and coronary heart disease: findings of a prospective study. Br Меd 1975; 2: 269-71.Hammond E.C., Carfinkel L. Aspirin and coronary heart disease: findings of a prospective study. Br Меd 1975; 2: 269-71.Jick H., Miettinen O.S. Regular aspirin use and myocardial infarction. Br Med J 1976; 1: 1057-8.Jick H., Miettinen O.S. Regular aspirin use and myocardial infarction. Br Med J 1976; 1: 1057-8.Final report an the aspirin component of the ongoing Physicians' Health Study. Steering Commitee of the Physicians' Health Study Research Croup. N Engl J Med 1989: 321: 129-35.Final report an the aspirin component of the ongoing Physicians' Health Study. Steering Commitee of the Physicians' Health Study Research Croup. N Engl J Med 1989: 321: 129-35.Peto R., Cray R., Collins R. et al. Randomized trial of prophylactic daily aspirin in British male doctors. Br Med J 1988; 296: 313-6.Peto R., Cray R., Collins R. et al. Randomized trial of prophylactic daily aspirin in British male doctors. Br Med J 1988; 296: 313-6.Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework. Lancet 1998; 351: 233-41.Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework. Lancet 1998; 351: 233-41.Hansson L., Zanchetti A., Carruthers S.G. et al. Effects of intensive blood-pressure lowering and low dose aspirin in patients with hypertension: principal results of Hypertension Optimal Treatment (HOT) randomized trial. Lancet 1988; 351: 1766-72.Hansson L., Zanchetti A., Carruthers S.G. et al. Effects of intensive blood-pressure lowering and low dose aspirin in patients with hypertension: principal results of Hypertension Optimal Treatment (HOT) randomized trial. Lancet 1988; 351: 1766-72.Collaborative Croup of the Primary Prevention Project. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Lancet 2001; 357: 89-95.Collaborative Croup of the Primary Prevention Project. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Lancet 2001; 357: 89-95.Hoyden M., Pignone M., Phillips C., Mulrow C. Aspirin for the primary prevention of cardiovascular events: A summary of the evidence for the US Preventive Services Task Force ANN Intern Med 2002; 136: 161-72.Hoyden M., Pignone M., Phillips C., Mulrow C. Aspirin for the primary prevention of cardiovascular events: A summary of the evidence for the US Preventive Services Task Force ANN Intern Med 2002; 136: 161-72.Manson J.E. Stampfer M.J., Coldilz G.A. et al. A prospective study of aspirin use and primary prevention of cardiovascular disease in women. JAMA 1991: 266: 521-7.Manson J.E. Stampfer M.J., Coldilz G.A. et al. A prospective study of aspirin use and primary prevention of cardiovascular disease in women. JAMA 1991: 266: 521-7.Ridker P., Cook N., Min Lee L. el. al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005: 352.Ridker P., Cook N., Min Lee L. el. al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005: 352.Expert Consensus Document on the use of antiplatelet agents. The Task Farce an the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European Society of Cardiology. Eur Heart J 2004: 25: 166-81.Expert Consensus Document on the use of antiplatelet agents. The Task Farce an the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European Society of Cardiology. Eur Heart J 2004: 25: 166-81.
The authors declare that there are no conflicts of interest present.